2021 के लिए बेस्ट 10 परफॉर्मिंग सेक्टर फंड्स

Updated on November 26, 2025 , 692 views

क्षेत्रम्यूचुअल फंड्स उस योजना का संदर्भ लें जो किसी विशेष क्षेत्र से संबंधित कंपनियों के इक्विटी शेयरों में अपने फंड के पैसे का एक प्रमुख हिस्सा निवेश करती है। इन योजनाओं की तलाश उन व्यक्तियों द्वारा की जाती है जो तलाश कर रहे हैंउच्च रिटर्न उनके निवेश पर a . के साथभारी जोखिम भूख। कुछ क्षेत्र जिनमें म्युचुअल फंड आम तौर पर अपनी योजनाओं की पेशकश करते हैं, उनमें बुनियादी ढांचा, फार्मास्युटिकल, बैंकिंग और वित्तीय सेवाएं, और प्राकृतिक संसाधन और नई ऊर्जा शामिल हैं। साल 2021 के लिए सेक्टोरल फंड्स का प्रदर्शन काफी अच्छा रहा है। में विकास के साथअर्थव्यवस्थाकई सेक्टोरल फंडों ने अपने निवेश पर सकारात्मक रिटर्न दिया है। तो, आइए वर्ष 2021 के लिए कुछ शीर्ष और सर्वश्रेष्ठ 10 प्रदर्शन करने वाले क्षेत्र के म्यूचुअल फंड पर नजर डालते हैंआधार उनके प्रदर्शन (रिटर्न) का।

Ready to Invest?
Talk to our investment specialist

प्रदर्शन के आधार पर 2021 के लिए शीर्ष 10 प्रदर्शन करने वाले क्षेत्र के म्युचुअल फंड

Fund	NAV	Net Assets (Cr)	2024 (%)	2023 (%)	2022 (%)	2021 (%)	2020 (%)
LIC MF Infrastructure Fund Growth	₹49.6653 ↓ -0.05	₹1,054	47.8	44.4	7.9	46.6	-0.1
UTI Healthcare Fund Growth	₹290.928 ↑ 1.47	₹1,125	42.9	38.2	-12.3	19.1	67.4
SBI Healthcare Opportunities Fund Growth	₹434.594 ↓ -0.65	₹4,082	42.2	38.2	-6	20.1	65.8
TATA India Pharma & Healthcare Fund Growth	₹30.9015 ↑ 0.16	₹1,325	40.4	36.6	-8	19.1	64.4
Bandhan Infrastructure Fund Growth	₹48.933 ↓ -0.13	₹1,625	39.3	50.3	1.7	64.8	6.3
Franklin India Opportunities Fund Growth	₹261.391 ↑ 0.36	₹8,189	37.3	53.6	-1.9	29.7	27.3
Canara Robeco Infrastructure Growth	₹161.31 ↓ -0.42	₹936	35.3	41.2	9	56.1	9
Nippon India Pharma Fund Growth	₹520.009 ↑ 2.48	₹8,346	34	39.2	-9.9	23.9	66.4
Invesco India Infrastructure Fund Growth	₹61.27 ↓ -0.28	₹1,527	33.2	51.1	2.3	55.4	16.2
Kotak Infrastructure & Economic Reform Fund Growth	₹65.68 ↓ -0.30	₹2,425	32.4	37.3	15.6	57.3	3.4
Note: Returns up to 1 year are on absolute basis & more than 1 year are on CAGR basis. as on 28 Nov 25

Research Highlights & Commentary of 10 Funds showcased

Commentary	LIC MF Infrastructure Fund	UTI Healthcare Fund	SBI Healthcare Opportunities Fund	TATA India Pharma & Healthcare Fund	Bandhan Infrastructure Fund	Franklin India Opportunities Fund	Canara Robeco Infrastructure	Nippon India Pharma Fund	Invesco India Infrastructure Fund	Kotak Infrastructure & Economic Reform Fund
Point 1	Bottom quartile AUM (₹1,054 Cr).	Bottom quartile AUM (₹1,125 Cr).	Upper mid AUM (₹4,082 Cr).	Lower mid AUM (₹1,325 Cr).	Upper mid AUM (₹1,625 Cr).	Top quartile AUM (₹8,189 Cr).	Bottom quartile AUM (₹936 Cr).	Highest AUM (₹8,346 Cr).	Lower mid AUM (₹1,527 Cr).	Upper mid AUM (₹2,425 Cr).
Point 2	Established history (17+ yrs).	Oldest track record among peers (26 yrs).	Established history (20+ yrs).	Established history (9+ yrs).	Established history (14+ yrs).	Established history (25+ yrs).	Established history (20+ yrs).	Established history (21+ yrs).	Established history (18+ yrs).	Established history (17+ yrs).
Point 3	Not Rated.	Rating: 1★ (lower mid).	Rating: 2★ (upper mid).	Not Rated.	Top rated.	Rating: 3★ (upper mid).	Not Rated.	Rating: 2★ (lower mid).	Rating: 3★ (upper mid).	Rating: 4★ (top quartile).
Point 4	Risk profile: High.	Risk profile: High.	Risk profile: High.	Risk profile: High.	Risk profile: High.	Risk profile: Moderately High.	Risk profile: High.	Risk profile: High.	Risk profile: High.	Risk profile: High.
Point 5	5Y return: 27.98% (upper mid).	5Y return: 16.86% (bottom quartile).	5Y return: 18.63% (lower mid).	5Y return: 16.96% (bottom quartile).	5Y return: 29.13% (top quartile).	5Y return: 24.87% (lower mid).	5Y return: 29.00% (top quartile).	5Y return: 16.95% (bottom quartile).	5Y return: 26.36% (upper mid).	5Y return: 27.79% (upper mid).
Point 6	3Y return: 26.63% (top quartile).	3Y return: 24.04% (lower mid).	3Y return: 24.16% (upper mid).	3Y return: 22.02% (bottom quartile).	3Y return: 24.77% (upper mid).	3Y return: 28.74% (top quartile).	3Y return: 24.18% (upper mid).	3Y return: 21.74% (bottom quartile).	3Y return: 22.87% (lower mid).	3Y return: 20.41% (bottom quartile).
Point 7	1Y return: -2.40% (bottom quartile).	1Y return: 3.15% (upper mid).	1Y return: 4.22% (top quartile).	1Y return: 3.50% (upper mid).	1Y return: -5.61% (bottom quartile).	1Y return: 4.54% (top quartile).	1Y return: 1.77% (lower mid).	1Y return: 3.77% (upper mid).	1Y return: -5.80% (bottom quartile).	1Y return: -1.96% (lower mid).
Point 8	Alpha: -6.32 (bottom quartile).	Alpha: -0.28 (lower mid).	Alpha: -0.29 (lower mid).	Alpha: 1.68 (top quartile).	Alpha: 0.00 (upper mid).	Alpha: 0.68 (top quartile).	Alpha: 0.00 (upper mid).	Alpha: -2.97 (bottom quartile).	Alpha: 0.00 (upper mid).	Alpha: -8.58 (bottom quartile).
Point 9	Sharpe: -0.04 (upper mid).	Sharpe: -0.18 (lower mid).	Sharpe: -0.18 (lower mid).	Sharpe: -0.28 (bottom quartile).	Sharpe: -0.31 (bottom quartile).	Sharpe: 0.06 (top quartile).	Sharpe: -0.02 (top quartile).	Sharpe: -0.35 (bottom quartile).	Sharpe: -0.17 (upper mid).	Sharpe: -0.14 (upper mid).
Point 10	Information ratio: 0.40 (upper mid).	Information ratio: 0.00 (upper mid).	Information ratio: 0.17 (upper mid).	Information ratio: 0.56 (top quartile).	Information ratio: 0.00 (lower mid).	Information ratio: 1.78 (top quartile).	Information ratio: 0.00 (lower mid).	Information ratio: -0.76 (bottom quartile).	Information ratio: 0.00 (bottom quartile).	Information ratio: -0.11 (bottom quartile).

LIC MF Infrastructure Fund

Bottom quartile AUM (₹1,054 Cr).
Established history (17+ yrs).
Not Rated.
Risk profile: High.
5Y return: 27.98% (upper mid).
3Y return: 26.63% (top quartile).
1Y return: -2.40% (bottom quartile).
Alpha: -6.32 (bottom quartile).
Sharpe: -0.04 (upper mid).
Information ratio: 0.40 (upper mid).

UTI Healthcare Fund

Bottom quartile AUM (₹1,125 Cr).
Oldest track record among peers (26 yrs).
Rating: 1★ (lower mid).
Risk profile: High.
5Y return: 16.86% (bottom quartile).
3Y return: 24.04% (lower mid).
1Y return: 3.15% (upper mid).
Alpha: -0.28 (lower mid).
Sharpe: -0.18 (lower mid).
Information ratio: 0.00 (upper mid).

SBI Healthcare Opportunities Fund

Upper mid AUM (₹4,082 Cr).
Established history (20+ yrs).
Rating: 2★ (upper mid).
Risk profile: High.
5Y return: 18.63% (lower mid).
3Y return: 24.16% (upper mid).
1Y return: 4.22% (top quartile).
Alpha: -0.29 (lower mid).
Sharpe: -0.18 (lower mid).
Information ratio: 0.17 (upper mid).

TATA India Pharma & Healthcare Fund

Lower mid AUM (₹1,325 Cr).
Established history (9+ yrs).
Not Rated.
Risk profile: High.
5Y return: 16.96% (bottom quartile).
3Y return: 22.02% (bottom quartile).
1Y return: 3.50% (upper mid).
Alpha: 1.68 (top quartile).
Sharpe: -0.28 (bottom quartile).
Information ratio: 0.56 (top quartile).

Bandhan Infrastructure Fund

Upper mid AUM (₹1,625 Cr).
Established history (14+ yrs).
Top rated.
Risk profile: High.
5Y return: 29.13% (top quartile).
3Y return: 24.77% (upper mid).
1Y return: -5.61% (bottom quartile).
Alpha: 0.00 (upper mid).
Sharpe: -0.31 (bottom quartile).
Information ratio: 0.00 (lower mid).

Franklin India Opportunities Fund

Top quartile AUM (₹8,189 Cr).
Established history (25+ yrs).
Rating: 3★ (upper mid).
Risk profile: Moderately High.
5Y return: 24.87% (lower mid).
3Y return: 28.74% (top quartile).
1Y return: 4.54% (top quartile).
Alpha: 0.68 (top quartile).
Sharpe: 0.06 (top quartile).
Information ratio: 1.78 (top quartile).

Canara Robeco Infrastructure

Bottom quartile AUM (₹936 Cr).
Established history (20+ yrs).
Not Rated.
Risk profile: High.
5Y return: 29.00% (top quartile).
3Y return: 24.18% (upper mid).
1Y return: 1.77% (lower mid).
Alpha: 0.00 (upper mid).
Sharpe: -0.02 (top quartile).
Information ratio: 0.00 (lower mid).

Nippon India Pharma Fund

Highest AUM (₹8,346 Cr).
Established history (21+ yrs).
Rating: 2★ (lower mid).
Risk profile: High.
5Y return: 16.95% (bottom quartile).
3Y return: 21.74% (bottom quartile).
1Y return: 3.77% (upper mid).
Alpha: -2.97 (bottom quartile).
Sharpe: -0.35 (bottom quartile).
Information ratio: -0.76 (bottom quartile).

Invesco India Infrastructure Fund

Lower mid AUM (₹1,527 Cr).
Established history (18+ yrs).
Rating: 3★ (upper mid).
Risk profile: High.
5Y return: 26.36% (upper mid).
3Y return: 22.87% (lower mid).
1Y return: -5.80% (bottom quartile).
Alpha: 0.00 (upper mid).
Sharpe: -0.17 (upper mid).
Information ratio: 0.00 (bottom quartile).

Kotak Infrastructure & Economic Reform Fund

Upper mid AUM (₹2,425 Cr).
Established history (17+ yrs).
Rating: 4★ (top quartile).
Risk profile: High.
5Y return: 27.79% (upper mid).
3Y return: 20.41% (bottom quartile).
1Y return: -1.96% (lower mid).
Alpha: -8.58 (bottom quartile).
Sharpe: -0.14 (upper mid).
Information ratio: -0.11 (bottom quartile).

2021 के लिए बेस्ट परफॉर्मिंग सेक्टर फंड्स

1. LIC MF Infrastructure Fund

The investment objective of the scheme is to provide long term growth from a portfolio of equity / equity related instruments of companies engaged either directly or indirectly in the infrastructure sector.

Research Highlights for LIC MF Infrastructure Fund

Bottom quartile AUM (₹1,054 Cr).
Established history (17+ yrs).
Not Rated.
Risk profile: High.
5Y return: 27.98% (upper mid).
3Y return: 26.63% (top quartile).
1Y return: -2.40% (bottom quartile).
Alpha: -6.32 (bottom quartile).
Sharpe: -0.04 (upper mid).
Information ratio: 0.40 (upper mid).

Below is the key information for LIC MF Infrastructure Fund

LIC MF Infrastructure Fund Growth
Launch Date	29 Feb 08
NAV (28 Nov 25)	₹49.6653 ↓ -0.05 (-0.11 %)
Net Assets (Cr)	₹1,054 on 31 Oct 25
Category	Equity - Sectoral
AMC	LIC Mutual Fund Asset Mgmt Co Ltd
Rating	Not Rated
Risk	High
Expense Ratio	2.21
Sharpe Ratio	-0.04
Information Ratio	0.4
Alpha Ratio	-6.32
Min Investment	5,000
Min SIP Investment	1,000
Exit Load	0-1 Years (1%),1 Years and above(NIL)

Growth of 10,000 investment over the years.

Date	Value
31 Oct 20	₹10,000
31 Oct 21	₹16,982
31 Oct 22	₹18,599
31 Oct 23	₹23,073
31 Oct 24	₹39,075
31 Oct 25	₹39,641

LIC MF Infrastructure Fund SIP Returns

Total investment amount is ₹300,000
expected amount after 5 Years is ₹598,181.
Net Profit of ₹298,181 Invest Now

Returns for LIC MF Infrastructure Fund

Returns up to 1 year are on absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 28 Nov 25

Duration	Returns
1 Month	-1.7%
3 Month	4.5%
6 Month	1.6%
1 Year	-2.4%
3 Year	26.6%
5 Year	28%
10 Year
15 Year
Since launch	9.5%

Historical performance (Yearly) on absolute basis

Year	Returns
2024	47.8%
2023	44.4%
2022	7.9%
2021	46.6%
2020	-0.1%
2019	13.3%
2018	-14.6%
2017	42.2%
2016	-2.2%
2015	-6.2%

Fund Manager information for LIC MF Infrastructure Fund

Name	Since	Tenure
Yogesh Patil	18 Sep 20	5.12 Yr.
Mahesh Bendre	1 Jul 24	1.34 Yr.

Data below for LIC MF Infrastructure Fund as on 31 Oct 25

Equity Sector Allocation

Sector	Value
Industrials	46.67%
Basic Materials	10.73%
Consumer Cyclical	7.92%
Financial Services	7.74%
Utility	5.33%
Technology	4.46%
Real Estate	3.56%
Health Care	3.4%
Communication Services	3.11%
Energy	0.98%

Asset Allocation

Asset Class	Value
Cash	5.56%
Equity	94.44%

Top Securities Holdings / Portfolio

Name	Holding	Value	Quantity
Shakti Pumps (India) Ltd (Industrials) Equity, Since 31 Mar 24 \| SHAKTIPUMP	5%	₹57 Cr	693,857
Larsen & Toubro Ltd (Industrials) Equity, Since 30 Apr 09 \| LT	4%	₹44 Cr	109,584
Afcons Infrastructure Ltd (Industrials) Equity, Since 31 Oct 24 \| AFCONS	3%	₹34 Cr	769,765
REC Ltd (Financial Services) Equity, Since 31 Jul 23 \| 532955	3%	₹34 Cr	911,009
Avalon Technologies Ltd (Technology) Equity, Since 31 Jul 23 \| AVALON	3%	₹34 Cr	286,134 ↓ -24,481
Apollo Hospitals Enterprise Ltd (Healthcare) Equity, Since 30 Jun 25 \| APOLLOHOSP	3%	₹34 Cr	44,149
Garware Hi-Tech Films Ltd (Basic Materials) Equity, Since 31 Aug 23 \| 500655	3%	₹32 Cr	94,287
Bharat Bijlee Ltd (Industrials) Equity, Since 31 Jul 22 \| BBL	3%	₹28 Cr	93,633 ↑ 13,500
Cummins India Ltd (Industrials) Equity, Since 31 May 21 \| 500480	3%	₹27 Cr	62,276
Schneider Electric Infrastructure Ltd (Industrials) Equity, Since 31 Dec 23 \| SCHNEIDER	3%	₹27 Cr	319,302

2. UTI Healthcare Fund

(Erstwhile UTI Pharma & Healthcare Fund)

The Investment objective of the Scheme is capital appreciation through investments in equities and equity related instruments of the Pharma & Healthcare sectors.

Research Highlights for UTI Healthcare Fund

Bottom quartile AUM (₹1,125 Cr).
Oldest track record among peers (26 yrs).
Rating: 1★ (lower mid).
Risk profile: High.
5Y return: 16.86% (bottom quartile).
3Y return: 24.04% (lower mid).
1Y return: 3.15% (upper mid).
Alpha: -0.28 (lower mid).
Sharpe: -0.18 (lower mid).
Information ratio: 0.00 (upper mid).

Below is the key information for UTI Healthcare Fund

UTI Healthcare Fund Growth
Launch Date	28 Jun 99
NAV (28 Nov 25)	₹290.928 ↑ 1.47 (0.51 %)
Net Assets (Cr)	₹1,125 on 31 Oct 25
Category	Equity - Sectoral
AMC	UTI Asset Management Company Ltd
Rating	☆
Risk	High
Expense Ratio	2.26
Sharpe Ratio	-0.18
Information Ratio	0
Alpha Ratio	-0.28
Min Investment	5,000
Min SIP Investment	500
Exit Load	0-1 Years (1%),1 Years and above(NIL)

Growth of 10,000 investment over the years.

Date	Value
31 Oct 20	₹10,000
31 Oct 21	₹12,799
31 Oct 22	₹12,052
31 Oct 23	₹14,059
31 Oct 24	₹22,392
31 Oct 25	₹22,840

UTI Healthcare Fund SIP Returns

Total investment amount is ₹300,000
expected amount after 5 Years is ₹458,689.
Net Profit of ₹158,689 Invest Now

Returns for UTI Healthcare Fund

Returns up to 1 year are on absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 28 Nov 25

Duration	Returns
1 Month	-0.2%
3 Month	0.6%
6 Month	5.5%
1 Year	3.2%
3 Year	24%
5 Year	16.9%
10 Year
15 Year
Since launch	14.8%

Historical performance (Yearly) on absolute basis

Year	Returns
2024	42.9%
2023	38.2%
2022	-12.3%
2021	19.1%
2020	67.4%
2019	1.2%
2018	-7.5%
2017	6.2%
2016	-9.7%
2015	12.4%

Fund Manager information for UTI Healthcare Fund

Name	Since	Tenure
Kamal Gada	2 May 22	3.5 Yr.

Data below for UTI Healthcare Fund as on 31 Oct 25

Equity Sector Allocation

Sector	Value
Health Care	97.05%
Basic Materials	1.08%

Asset Allocation

Asset Class	Value
Cash	1.88%
Equity	98.12%

Top Securities Holdings / Portfolio

Name	Holding	Value	Quantity
Sun Pharmaceuticals Industries Ltd (Healthcare) Equity, Since 31 Oct 06 \| SUNPHARMA	10%	₹110 Cr	650,000 ↓ -11,016
Ajanta Pharma Ltd (Healthcare) Equity, Since 31 Jul 17 \| 532331	6%	₹70 Cr	285,000 ↑ 35,000
Lupin Ltd (Healthcare) Equity, Since 28 Feb 25 \| 500257	6%	₹63 Cr	319,570 ↑ 49,570
Glenmark Pharmaceuticals Ltd (Healthcare) Equity, Since 31 Mar 24 \| 532296	4%	₹46 Cr	245,000 ↑ 35,000
Cipla Ltd (Healthcare) Equity, Since 31 Jan 03 \| 500087	4%	₹42 Cr	280,000 ↓ -120,000
Procter & Gamble Health Ltd (Healthcare) Equity, Since 31 Dec 20 \| PGHL	4%	₹41 Cr	67,014 ↓ -2,306
Gland Pharma Ltd (Healthcare) Equity, Since 30 Nov 20 \| GLAND	4%	₹41 Cr	213,141 ↑ 13,844
Apollo Hospitals Enterprise Ltd (Healthcare) Equity, Since 30 Apr 21 \| APOLLOHOSP	4%	₹41 Cr	53,000
Dr Reddy's Laboratories Ltd (Healthcare) Equity, Since 28 Feb 18 \| DRREDDY	4%	₹40 Cr	335,000
Alkem Laboratories Ltd (Healthcare) Equity, Since 31 May 21 \| ALKEM	4%	₹40 Cr	72,000

3. SBI Healthcare Opportunities Fund

(Erstwhile SBI Pharma Fund)

To provide the investors maximum growth opportunity through equity investments in stocks of growth oriented sectors of the economy.

Research Highlights for SBI Healthcare Opportunities Fund

Upper mid AUM (₹4,082 Cr).
Established history (20+ yrs).
Rating: 2★ (upper mid).
Risk profile: High.
5Y return: 18.63% (lower mid).
3Y return: 24.16% (upper mid).
1Y return: 4.22% (top quartile).
Alpha: -0.29 (lower mid).
Sharpe: -0.18 (lower mid).
Information ratio: 0.17 (upper mid).

Below is the key information for SBI Healthcare Opportunities Fund

SBI Healthcare Opportunities Fund Growth
Launch Date	31 Dec 04
NAV (27 Nov 25)	₹434.594 ↓ -0.65 (-0.15 %)
Net Assets (Cr)	₹4,082 on 31 Oct 25
Category	Equity - Sectoral
AMC	SBI Funds Management Private Limited
Rating	☆☆
Risk	High
Expense Ratio	1.97
Sharpe Ratio	-0.18
Information Ratio	0.17
Alpha Ratio	-0.29
Min Investment	5,000
Min SIP Investment	500
Exit Load	0-15 Days (0.5%),15 Days and above(NIL)

Growth of 10,000 investment over the years.

Date	Value
31 Oct 20	₹10,000
31 Oct 21	₹12,709
31 Oct 22	₹12,920
31 Oct 23	₹15,414
31 Oct 24	₹24,279
31 Oct 25	₹24,895

SBI Healthcare Opportunities Fund SIP Returns

Total investment amount is ₹300,000
expected amount after 5 Years is ₹481,656.
Net Profit of ₹181,656 Invest Now

Returns for SBI Healthcare Opportunities Fund

Returns up to 1 year are on absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 28 Nov 25

Duration	Returns
1 Month	-0.5%
3 Month	0.5%
6 Month	3.9%
1 Year	4.2%
3 Year	24.2%
5 Year	18.6%
10 Year
15 Year
Since launch	15.3%

Historical performance (Yearly) on absolute basis

Year	Returns
2024	42.2%
2023	38.2%
2022	-6%
2021	20.1%
2020	65.8%
2019	-0.5%
2018	-9.9%
2017	2.1%
2016	-14%
2015	27.1%

Fund Manager information for SBI Healthcare Opportunities Fund

Name	Since	Tenure
Tanmaya Desai	1 Jun 11	14.43 Yr.

Data below for SBI Healthcare Opportunities Fund as on 31 Oct 25

Equity Sector Allocation

Sector	Value
Health Care	89.67%
Basic Materials	6.39%

Asset Allocation

Asset Class	Value
Cash	3.93%
Equity	96.07%

Top Securities Holdings / Portfolio

Name	Holding	Value	Quantity
Sun Pharmaceuticals Industries Ltd (Healthcare) Equity, Since 31 Dec 17 \| SUNPHARMA	11%	₹456 Cr	2,700,000
Divi's Laboratories Ltd (Healthcare) Equity, Since 31 Mar 12 \| DIVISLAB	7%	₹296 Cr	440,000
Max Healthcare Institute Ltd Ordinary Shares (Healthcare) Equity, Since 31 Mar 21 \| MAXHEALTH	6%	₹230 Cr	2,000,000
Cipla Ltd (Healthcare) Equity, Since 31 Aug 16 \| 500087	4%	₹180 Cr	1,200,000
Lonza Group Ltd ADR (Healthcare) Equity, Since 31 Jan 24 \| LZAGY	4%	₹165 Cr	270,000
Lupin Ltd (Healthcare) Equity, Since 31 Aug 23 \| 500257	4%	₹165 Cr	840,000
Acutaas Chemicals Ltd (Basic Materials) Equity, Since 30 Jun 24 \| 543349	4%	₹155 Cr	900,000
Fortis Healthcare Ltd (Healthcare) Equity, Since 30 Apr 21 \| 532843	4%	₹153 Cr	1,500,000
Torrent Pharmaceuticals Ltd (Healthcare) Equity, Since 30 Jun 21 \| TORNTPHARM	3%	₹142 Cr	400,000
Jupiter Life Line Hospitals Ltd (Healthcare) Equity, Since 31 Aug 23 \| JLHL	3%	₹141 Cr	890,405 ↑ 61,698

4. TATA India Pharma & Healthcare Fund

The investment objective of the scheme is to seek long term capital appreciation by investing atleast 80% of its net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.However, there is no assurance or guarantee that the investment objective of the Scheme will be achieved.The Scheme does not assure or guarantee any returns.

Research Highlights for TATA India Pharma & Healthcare Fund

Lower mid AUM (₹1,325 Cr).
Established history (9+ yrs).
Not Rated.
Risk profile: High.
5Y return: 16.96% (bottom quartile).
3Y return: 22.02% (bottom quartile).
1Y return: 3.50% (upper mid).
Alpha: 1.68 (top quartile).
Sharpe: -0.28 (bottom quartile).
Information ratio: 0.56 (top quartile).

Below is the key information for TATA India Pharma & Healthcare Fund

TATA India Pharma & Healthcare Fund Growth
Launch Date	28 Dec 15
NAV (28 Nov 25)	₹30.9015 ↑ 0.16 (0.52 %)
Net Assets (Cr)	₹1,325 on 31 Oct 25
Category	Equity - Sectoral
AMC	Tata Asset Management Limited
Rating	Not Rated
Risk	High
Expense Ratio	2.17
Sharpe Ratio	-0.28
Information Ratio	0.56
Alpha Ratio	1.68
Min Investment	5,000
Min SIP Investment	150
Exit Load	0-3 Months (0.25%),3 Months and above(NIL)

Growth of 10,000 investment over the years.

Date	Value
31 Oct 20	₹10,000
31 Oct 21	₹12,776
31 Oct 22	₹12,763
31 Oct 23	₹14,596
31 Oct 24	₹22,921
31 Oct 25	₹22,928

TATA India Pharma & Healthcare Fund SIP Returns

Total investment amount is ₹300,000
expected amount after 5 Years is ₹458,689.
Net Profit of ₹158,689 Invest Now

Returns for TATA India Pharma & Healthcare Fund

Returns up to 1 year are on absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 28 Nov 25

Duration	Returns
1 Month	0.4%
3 Month	1.4%
6 Month	5.7%
1 Year	3.5%
3 Year	22%
5 Year	17%
10 Year
15 Year
Since launch	12%

Historical performance (Yearly) on absolute basis

Year	Returns
2024	40.4%
2023	36.6%
2022	-8%
2021	19.1%
2020	64.4%
2019	5.5%
2018	-2.6%
2017	4.7%
2016	-14.7%
2015

Fund Manager information for TATA India Pharma & Healthcare Fund

Name	Since	Tenure
Rajat Srivastava	16 Sep 24	1.13 Yr.

Data below for TATA India Pharma & Healthcare Fund as on 31 Oct 25

Equity Sector Allocation

Sector	Value
Health Care	96.33%
Basic Materials	2.17%

Asset Allocation

Asset Class	Value
Cash	1.5%
Equity	98.5%

Top Securities Holdings / Portfolio

Name	Holding	Value	Quantity
Sun Pharmaceuticals Industries Ltd (Healthcare) Equity, Since 31 Jan 16 \| SUNPHARMA	10%	₹127 Cr	751,703 ↓ -63,780
Apollo Hospitals Enterprise Ltd (Healthcare) Equity, Since 31 Dec 16 \| APOLLOHOSP	5%	₹68 Cr	88,528
HealthCare Global Enterprises Ltd (Healthcare) Equity, Since 31 Dec 18 \| HCG	5%	₹66 Cr	880,171 ↓ -62,282
Lupin Ltd (Healthcare) Equity, Since 30 Nov 17 \| 500257	5%	₹65 Cr	330,887
Max Healthcare Institute Ltd Ordinary Shares (Healthcare) Equity, Since 31 Jul 25 \| MAXHEALTH	5%	₹62 Cr	543,979 ↑ 85,255
Torrent Pharmaceuticals Ltd (Healthcare) Equity, Since 31 Aug 22 \| TORNTPHARM	5%	₹60 Cr	168,394
Alkem Laboratories Ltd (Healthcare) Equity, Since 31 Aug 20 \| ALKEM	4%	₹59 Cr	106,435
Abbott India Ltd (Healthcare) Equity, Since 30 Sep 25 \| ABBOTINDIA	4%	₹53 Cr	18,387 ↑ 5,535
Cipla Ltd (Healthcare) Equity, Since 30 Apr 20 \| 500087	4%	₹52 Cr	346,084 ↓ -72,784
Ipca Laboratories Ltd (Healthcare) Equity, Since 31 Aug 16 \| 524494	4%	₹47 Cr	370,697 ↑ 60,605

5. Bandhan Infrastructure Fund

The investment objective of the scheme is to seek to generate long-term capital growth through an active diversified portfolio of predominantly equity and equity related instruments of companies that are participating in and benefiting from growth in Indian infrastructure and infrastructural related activities. However, there can be no assurance that the investment objective of the scheme will be realized.

Research Highlights for Bandhan Infrastructure Fund

Upper mid AUM (₹1,625 Cr).
Established history (14+ yrs).
Top rated.
Risk profile: High.
5Y return: 29.13% (top quartile).
3Y return: 24.77% (upper mid).
1Y return: -5.61% (bottom quartile).
Alpha: 0.00 (upper mid).
Sharpe: -0.31 (bottom quartile).
Information ratio: 0.00 (lower mid).

Below is the key information for Bandhan Infrastructure Fund

Bandhan Infrastructure Fund Growth
Launch Date	8 Mar 11
NAV (28 Nov 25)	₹48.933 ↓ -0.13 (-0.26 %)
Net Assets (Cr)	₹1,625 on 31 Oct 25
Category	Equity - Sectoral
AMC	IDFC Asset Management Company Limited
Rating	☆☆☆☆☆
Risk	High
Expense Ratio	2.1
Sharpe Ratio	-0.31
Information Ratio	0
Alpha Ratio	0
Min Investment	5,000
Min SIP Investment	100
Exit Load	0-365 Days (1%),365 Days and above(NIL)

Growth of 10,000 investment over the years.

Date	Value
31 Oct 20	₹10,000
31 Oct 21	₹20,050
31 Oct 22	₹20,377
31 Oct 23	₹26,163
31 Oct 24	₹43,146
31 Oct 25	₹41,438

Bandhan Infrastructure Fund SIP Returns

Total investment amount is ₹300,000
expected amount after 5 Years is ₹627,226.
Net Profit of ₹327,226 Invest Now

Returns for Bandhan Infrastructure Fund

Returns up to 1 year are on absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 28 Nov 25

Duration	Returns
1 Month	-2.3%
3 Month	0.5%
6 Month	-3.1%
1 Year	-5.6%
3 Year	24.8%
5 Year	29.1%
10 Year
15 Year
Since launch	11.4%

Historical performance (Yearly) on absolute basis

Year	Returns
2024	39.3%
2023	50.3%
2022	1.7%
2021	64.8%
2020	6.3%
2019	-5.3%
2018	-25.9%
2017	58.7%
2016	10.7%
2015	-0.2%

Fund Manager information for Bandhan Infrastructure Fund

Name	Since	Tenure
Vishal Biraia	24 Jan 24	1.77 Yr.
Ritika Behera	7 Oct 23	2.07 Yr.
Gaurav Satra	7 Jun 24	1.4 Yr.

Data below for Bandhan Infrastructure Fund as on 31 Oct 25

Equity Sector Allocation

Sector	Value
Industrials	53.35%
Utility	12.64%
Basic Materials	8.05%
Communication Services	4.41%
Energy	4.1%
Technology	3.65%
Financial Services	2.97%
Health Care	2.22%
Real Estate	1.44%
Consumer Cyclical	1.17%

Asset Allocation

Asset Class	Value
Cash	6.01%
Equity	93.99%

Top Securities Holdings / Portfolio

Name	Holding	Value	Quantity
Larsen & Toubro Ltd (Industrials) Equity, Since 29 Feb 12 \| LT	5%	₹82 Cr	204,050 ↓ -2,212
Kirloskar Brothers Ltd (Industrials) Equity, Since 31 Dec 17 \| KIRLOSBROS	5%	₹80 Cr	426,772 ↓ -6,414
Bharti Airtel Ltd (Communication Services) Equity, Since 30 Apr 19 \| BHARTIARTL	4%	₹72 Cr	348,551 ↓ -3,779
Reliance Industries Ltd (Energy) Equity, Since 30 Jun 24 \| RELIANCE	4%	₹67 Cr	447,851 ↓ -4,855
Bharat Electronics Ltd (Industrials) Equity, Since 31 Oct 19 \| BEL	4%	₹60 Cr	1,416,343 ↓ -15,357
UltraTech Cement Ltd (Basic Materials) Equity, Since 31 Mar 14 \| 532538	4%	₹59 Cr	49,239 ↓ -533
GPT Infraprojects Ltd (Industrials) Equity, Since 30 Nov 17 \| GPTINFRA	3%	₹51 Cr	4,733,244
InterGlobe Aviation Ltd (Industrials) Equity, Since 31 Aug 24 \| INDIGO	3%	₹47 Cr	82,988 ↓ -899
PTC India Financial Services Ltd (Financial Services) Equity, Since 31 Dec 23 \| PFS	3%	₹45 Cr	12,400,122
Adani Ports & Special Economic Zone Ltd (Industrials) Equity, Since 31 Dec 23 \| ADANIPORTS	3%	₹44 Cr	303,494 ↓ -3,290

6. Franklin India Opportunities Fund

The investment objective of Franklin India Opportunities Fund (FIOF) is to generate capital appreciation by capitalizing on the long-term growth opportunities in the Indian economy.

Research Highlights for Franklin India Opportunities Fund

Top quartile AUM (₹8,189 Cr).
Established history (25+ yrs).
Rating: 3★ (upper mid).
Risk profile: Moderately High.
5Y return: 24.87% (lower mid).
3Y return: 28.74% (top quartile).
1Y return: 4.54% (top quartile).
Alpha: 0.68 (top quartile).
Sharpe: 0.06 (top quartile).
Information ratio: 1.78 (top quartile).

Below is the key information for Franklin India Opportunities Fund

Franklin India Opportunities Fund Growth
Launch Date	21 Feb 00
NAV (28 Nov 25)	₹261.391 ↑ 0.36 (0.14 %)
Net Assets (Cr)	₹8,189 on 31 Oct 25
Category	Equity - Sectoral
AMC	Franklin Templeton Asst Mgmt(IND)Pvt Ltd
Rating	☆☆☆
Risk	Moderately High
Expense Ratio	1.83
Sharpe Ratio	0.06
Information Ratio	1.78
Alpha Ratio	0.68
Min Investment	5,000
Min SIP Investment	500
Exit Load	0-1 Years (1%),1 Years and above(NIL)

Growth of 10,000 investment over the years.

Date	Value
31 Oct 20	₹10,000
31 Oct 21	₹16,039
31 Oct 22	₹15,668
31 Oct 23	₹19,891
31 Oct 24	₹32,356
31 Oct 25	₹34,323

Franklin India Opportunities Fund SIP Returns

Total investment amount is ₹300,000
expected amount after 5 Years is ₹556,833.
Net Profit of ₹256,833 Invest Now

Returns for Franklin India Opportunities Fund

Returns up to 1 year are on absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 28 Nov 25

Duration	Returns
1 Month	-1%
3 Month	2.6%
6 Month	6.5%
1 Year	4.5%
3 Year	28.7%
5 Year	24.9%
10 Year
15 Year
Since launch	13.5%

Historical performance (Yearly) on absolute basis

Year	Returns
2024	37.3%
2023	53.6%
2022	-1.9%
2021	29.7%
2020	27.3%
2019	5.4%
2018	-10.1%
2017	35.6%
2016	4.2%
2015	2.3%

Fund Manager information for Franklin India Opportunities Fund

Name	Since	Tenure
Kiran Sebastian	7 Feb 22	3.73 Yr.
R. Janakiraman	1 Apr 13	12.59 Yr.
Sandeep Manam	18 Oct 21	4.04 Yr.

Data below for Franklin India Opportunities Fund as on 31 Oct 25

Equity Sector Allocation

Sector	Value
Financial Services	24.53%
Consumer Cyclical	16.82%
Health Care	13%
Technology	12.83%
Basic Materials	8.66%
Communication Services	5.45%
Industrials	4.35%
Energy	3.02%
Utility	2.61%
Consumer Defensive	1.62%
Real Estate	0.55%

Asset Allocation

Asset Class	Value
Cash	6.34%
Equity	93.64%

Top Securities Holdings / Portfolio

Name	Holding	Value	Quantity
Axis Bank Ltd (Financial Services) Equity, Since 30 Apr 25 \| 532215	6%	₹487 Cr	3,948,707 ↑ 998,430
State Bank of India (Financial Services) Equity, Since 31 Oct 25 \| SBIN	6%	₹467 Cr	4,981,006 ↑ 4,981,006
Eternal Ltd (Consumer Cyclical) Equity, Since 31 Aug 23 \| 543320	4%	₹303 Cr	9,548,090
Maruti Suzuki India Ltd (Consumer Cyclical) Equity, Since 30 Apr 25 \| MARUTI	3%	₹274 Cr	169,582
Reliance Industries Ltd (Energy) Equity, Since 30 Apr 22 \| RELIANCE	3%	₹247 Cr	1,661,519 ↓ -810,710
Bharti Airtel Ltd (Communication Services) Equity, Since 31 Jan 24 \| BHARTIARTL	3%	₹238 Cr	1,158,502
Mphasis Ltd (Technology) Equity, Since 30 Nov 24 \| 526299	3%	₹225 Cr	814,231
Mahindra & Mahindra Ltd (Consumer Cyclical) Equity, Since 31 May 24 \| M&M	3%	₹222 Cr	637,966
NTPC Ltd (Utilities) Equity, Since 31 Aug 22 \| 532555	3%	₹213 Cr	6,333,312
HDFC Bank Ltd (Financial Services) Equity, Since 31 May 24 \| HDFCBANK	3%	₹213 Cr	2,153,280 ↓ -1,934,662

7. Canara Robeco Infrastructure

T o g e n e r a t e income/capital appreciation by investing in equities and equity related instruments of companies in the infrastructure sector. However, there can be no assurance that the investment objective of the scheme will be realized.

Research Highlights for Canara Robeco Infrastructure

Bottom quartile AUM (₹936 Cr).
Established history (20+ yrs).
Not Rated.
Risk profile: High.
5Y return: 29.00% (top quartile).
3Y return: 24.18% (upper mid).
1Y return: 1.77% (lower mid).
Alpha: 0.00 (upper mid).
Sharpe: -0.02 (top quartile).
Information ratio: 0.00 (lower mid).

Below is the key information for Canara Robeco Infrastructure

Canara Robeco Infrastructure Growth
Launch Date	2 Dec 05
NAV (28 Nov 25)	₹161.31 ↓ -0.42 (-0.26 %)
Net Assets (Cr)	₹936 on 31 Oct 25
Category	Equity - Sectoral
AMC	Canara Robeco Asset Management Co. Ltd.
Rating	Not Rated
Risk	High
Expense Ratio	2.32
Sharpe Ratio	-0.02
Information Ratio	0
Alpha Ratio	0
Min Investment	5,000
Min SIP Investment	1,000
Exit Load	0-1 Years (1%),1 Years and above(NIL)

Growth of 10,000 investment over the years.

Date	Value
31 Oct 20	₹10,000
31 Oct 21	₹18,193
31 Oct 22	₹20,521
31 Oct 23	₹24,210
31 Oct 24	₹39,188
31 Oct 25	₹40,693

Canara Robeco Infrastructure SIP Returns

Total investment amount is ₹300,000
expected amount after 5 Years is ₹612,552.
Net Profit of ₹312,552 Invest Now

Returns for Canara Robeco Infrastructure

Returns up to 1 year are on absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 28 Nov 25

Duration	Returns
1 Month	-1.6%
3 Month	3%
6 Month	2.3%
1 Year	1.8%
3 Year	24.2%
5 Year	29%
10 Year
15 Year
Since launch	14.9%

Historical performance (Yearly) on absolute basis

Year	Returns
2024	35.3%
2023	41.2%
2022	9%
2021	56.1%
2020	9%
2019	2.3%
2018	-19.1%
2017	40.2%
2016	2.1%
2015	6.7%

Fund Manager information for Canara Robeco Infrastructure

Name	Since	Tenure
Vishal Mishra	26 Jun 21	4.35 Yr.
Shridatta Bhandwaldar	29 Sep 18	7.1 Yr.

Data below for Canara Robeco Infrastructure as on 31 Oct 25

Equity Sector Allocation

Sector	Value
Industrials	45.06%
Utility	11.84%
Basic Materials	8.75%
Energy	8.39%
Financial Services	7.27%
Technology	7.04%
Communication Services	3%
Consumer Cyclical	2.95%
Real Estate	1.39%

Asset Allocation

Asset Class	Value
Cash	4.31%
Equity	95.69%

Top Securities Holdings / Portfolio

Name	Holding	Value	Quantity
Larsen & Toubro Ltd (Industrials) Equity, Since 28 Feb 11 \| LT	10%	₹92 Cr	227,901 ↑ 15,000
Reliance Industries Ltd (Energy) Equity, Since 30 Apr 22 \| RELIANCE	4%	₹42 Cr	279,250
State Bank of India (Financial Services) Equity, Since 31 Jul 24 \| SBIN	4%	₹41 Cr	442,500
Bharat Electronics Ltd (Industrials) Equity, Since 31 Jul 19 \| BEL	4%	₹37 Cr	869,000
NTPC Ltd (Utilities) Equity, Since 30 Nov 18 \| 532555	4%	₹36 Cr	1,066,480
InterGlobe Aviation Ltd (Industrials) Equity, Since 31 Jan 23 \| INDIGO	3%	₹33 Cr	58,250
GE Vernova T&D India Ltd (Industrials) Equity, Since 31 Jan 24 \| 522275	3%	₹32 Cr	105,185
Tata Power Co Ltd (Utilities) Equity, Since 30 Sep 24 \| 500400	3%	₹32 Cr	785,000
CG Power & Industrial Solutions Ltd (Industrials) Equity, Since 31 Oct 23 \| 500093	3%	₹30 Cr	413,150 ↑ 30,000
Dixon Technologies (India) Ltd (Technology) Equity, Since 31 Oct 23 \| DIXON	3%	₹29 Cr	18,950

8. Nippon India Pharma Fund

The primary investment objective of the scheme is to seek to generate consistent returns by investing in equity and equity related or fixed income securities of Pharma and other associated companies.

Research Highlights for Nippon India Pharma Fund

Highest AUM (₹8,346 Cr).
Established history (21+ yrs).
Rating: 2★ (lower mid).
Risk profile: High.
5Y return: 16.95% (bottom quartile).
3Y return: 21.74% (bottom quartile).
1Y return: 3.77% (upper mid).
Alpha: -2.97 (bottom quartile).
Sharpe: -0.35 (bottom quartile).
Information ratio: -0.76 (bottom quartile).

Below is the key information for Nippon India Pharma Fund

Nippon India Pharma Fund Growth
Launch Date	5 Jun 04
NAV (28 Nov 25)	₹520.009 ↑ 2.48 (0.48 %)
Net Assets (Cr)	₹8,346 on 31 Oct 25
Category	Equity - Sectoral
AMC	Nippon Life Asset Management Ltd.
Rating	☆☆
Risk	High
Expense Ratio	1.81
Sharpe Ratio	-0.35
Information Ratio	-0.76
Alpha Ratio	-2.97
Min Investment	5,000
Min SIP Investment	100
Exit Load	0-1 Years (1%),1 Years and above(NIL)

Growth of 10,000 investment over the years.

Date	Value
31 Oct 20	₹10,000
31 Oct 21	₹13,485
31 Oct 22	₹13,065
31 Oct 23	₹15,358
31 Oct 24	₹23,207
31 Oct 25	₹23,085

Nippon India Pharma Fund SIP Returns

Total investment amount is ₹300,000
expected amount after 5 Years is ₹458,689.
Net Profit of ₹158,689 Invest Now

Returns for Nippon India Pharma Fund

Returns up to 1 year are on absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 28 Nov 25

Duration	Returns
1 Month	1.5%
3 Month	2.3%
6 Month	3.3%
1 Year	3.8%
3 Year	21.7%
5 Year	17%
10 Year
15 Year
Since launch	20.2%

Historical performance (Yearly) on absolute basis

Year	Returns
2024	34%
2023	39.2%
2022	-9.9%
2021	23.9%
2020	66.4%
2019	1.7%
2018	3.6%
2017	7.6%
2016	-10.6%
2015	19.4%

Fund Manager information for Nippon India Pharma Fund

Name	Since	Tenure
Sailesh Raj Bhan	1 Apr 05	20.6 Yr.
Kinjal Desai	25 May 18	7.44 Yr.
Lokesh Maru	5 Sep 25	0.16 Yr.
Divya Sharma	5 Sep 25	0.16 Yr.

Data below for Nippon India Pharma Fund as on 31 Oct 25

Equity Sector Allocation

Sector	Value
Health Care	99.66%

Asset Allocation

Asset Class	Value
Cash	0.34%
Equity	99.66%

Top Securities Holdings / Portfolio

Name	Holding	Value	Quantity
Sun Pharmaceuticals Industries Ltd (Healthcare) Equity, Since 31 Oct 09 \| SUNPHARMA	13%	₹1,058 Cr	6,256,349
Divi's Laboratories Ltd (Healthcare) Equity, Since 31 Mar 12 \| DIVISLAB	8%	₹674 Cr	1,000,031
Lupin Ltd (Healthcare) Equity, Since 31 Aug 08 \| 500257	7%	₹606 Cr	3,083,991
Cipla Ltd (Healthcare) Equity, Since 31 May 08 \| 500087	6%	₹525 Cr	3,495,054
Apollo Hospitals Enterprise Ltd (Healthcare) Equity, Since 30 Sep 20 \| APOLLOHOSP	6%	₹498 Cr	648,795
Dr Reddy's Laboratories Ltd (Healthcare) Equity, Since 30 Jun 11 \| DRREDDY	6%	₹469 Cr	3,916,074
Vijaya Diagnostic Centre Ltd (Healthcare) Equity, Since 30 Sep 21 \| 543350	3%	₹285 Cr	2,886,684
Medplus Health Services Ltd (Healthcare) Equity, Since 30 Nov 22 \| 543427	3%	₹277 Cr	3,627,277
Gland Pharma Ltd (Healthcare) Equity, Since 30 Nov 20 \| GLAND	3%	₹255 Cr	1,320,549
GlaxoSmithKline Pharmaceuticals Ltd (Healthcare) Equity, Since 31 Aug 22 \| GLAXO	3%	₹239 Cr	913,226

9. Invesco India Infrastructure Fund

The Scheme seeks to provide long term capital appreciation by investing in a portfolio that is predominantly constituted of equity and equity related instruments of infrastructure companies. However, there can be no assurance that the investment objective of the Scheme will be achieved.

Research Highlights for Invesco India Infrastructure Fund

Lower mid AUM (₹1,527 Cr).
Established history (18+ yrs).
Rating: 3★ (upper mid).
Risk profile: High.
5Y return: 26.36% (upper mid).
3Y return: 22.87% (lower mid).
1Y return: -5.80% (bottom quartile).
Alpha: 0.00 (upper mid).
Sharpe: -0.17 (upper mid).
Information ratio: 0.00 (bottom quartile).

Below is the key information for Invesco India Infrastructure Fund

Invesco India Infrastructure Fund Growth
Launch Date	21 Nov 07
NAV (28 Nov 25)	₹61.27 ↓ -0.28 (-0.45 %)
Net Assets (Cr)	₹1,527 on 31 Oct 25
Category	Equity - Sectoral
AMC	Invesco Asset Management (India) Private Ltd
Rating	☆☆☆
Risk	High
Expense Ratio	2.09
Sharpe Ratio	-0.17
Information Ratio	0
Alpha Ratio	0
Min Investment	5,000
Min SIP Investment	500
Exit Load	0-1 Years (1%),1 Years and above(NIL)

Growth of 10,000 investment over the years.

Date	Value
31 Oct 20	₹10,000
31 Oct 21	₹18,471
31 Oct 22	₹19,441
31 Oct 23	₹23,873
31 Oct 24	₹38,293
31 Oct 25	₹37,805

Invesco India Infrastructure Fund SIP Returns

Total investment amount is ₹300,000
expected amount after 5 Years is ₹584,107.
Net Profit of ₹284,107 Invest Now

Returns for Invesco India Infrastructure Fund

Returns up to 1 year are on absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 28 Nov 25

Duration	Returns
1 Month	-4%
3 Month	-2.1%
6 Month	-4.2%
1 Year	-5.8%
3 Year	22.9%
5 Year	26.4%
10 Year
15 Year
Since launch	10.6%

Historical performance (Yearly) on absolute basis

Year	Returns
2024	33.2%
2023	51.1%
2022	2.3%
2021	55.4%
2020	16.2%
2019	6.1%
2018	-15.8%
2017	48.1%
2016	0.8%
2015	-2.6%

Fund Manager information for Invesco India Infrastructure Fund

Name	Since	Tenure
Amit Nigam	3 Sep 20	5.16 Yr.
Sagar Gandhi	1 Mar 25	0.67 Yr.

Data below for Invesco India Infrastructure Fund as on 31 Oct 25

Equity Sector Allocation

Sector	Value
Industrials	55.7%
Basic Materials	10.06%
Consumer Cyclical	9.44%
Communication Services	6.05%
Real Estate	5.28%
Health Care	5.08%
Utility	3.52%
Technology	2.13%
Energy	1.61%

Asset Allocation

Asset Class	Value
Cash	1.12%
Equity	98.88%

Top Securities Holdings / Portfolio

Name	Holding	Value	Quantity
Bharti Airtel Ltd (Communication Services) Equity, Since 31 Aug 21 \| BHARTIARTL	6%	₹92 Cr	450,000 ↓ -51,000
Apollo Hospitals Enterprise Ltd (Healthcare) Equity, Since 30 Jun 24 \| APOLLOHOSP	5%	₹78 Cr	101,000 ↓ -4,153
InterGlobe Aviation Ltd (Industrials) Equity, Since 31 May 25 \| INDIGO	5%	₹71 Cr	126,000
Delhivery Ltd (Industrials) Equity, Since 31 Aug 24 \| 543529	4%	₹69 Cr	1,474,847
ZF Commercial Vehicle Control Systems India Ltd (Consumer Cyclical) Equity, Since 30 Jun 23 \| ZFCVINDIA	4%	₹60 Cr	48,000
PTC Industries Ltd (Industrials) Equity, Since 30 Sep 24 \| 539006	4%	₹58 Cr	33,363 ↓ -1,699
Ramco Cements Ltd (Basic Materials) Equity, Since 31 Jul 23 \| RAMCOCEM	4%	₹56 Cr	540,000
Supreme Industries Ltd (Industrials) Equity, Since 30 Apr 24 \| 509930	4%	₹55 Cr	145,191 ↑ 24,190
Larsen & Toubro Ltd (Industrials) Equity, Since 29 Feb 12 \| LT	3%	₹53 Cr	131,504 ↑ 27,319
Balkrishna Industries Ltd (Consumer Cyclical) Equity, Since 31 Jul 24 \| BALKRISIND	3%	₹48 Cr	210,000 ↑ 25,463

10. Kotak Infrastructure & Economic Reform Fund

The investment objective of the Scheme is to generate long-term capital appreciation from a diversified portfolio of predominantly (at least 65%) equity and equity-related securities of companies involved in economic development of India as a result of potential investments in infrastructure and unfolding economic reforms.

Research Highlights for Kotak Infrastructure & Economic Reform Fund

Upper mid AUM (₹2,425 Cr).
Established history (17+ yrs).
Rating: 4★ (top quartile).
Risk profile: High.
5Y return: 27.79% (upper mid).
3Y return: 20.41% (bottom quartile).
1Y return: -1.96% (lower mid).
Alpha: -8.58 (bottom quartile).
Sharpe: -0.14 (upper mid).
Information ratio: -0.11 (bottom quartile).

Below is the key information for Kotak Infrastructure & Economic Reform Fund

Kotak Infrastructure & Economic Reform Fund Growth
Launch Date	25 Feb 08
NAV (28 Nov 25)	₹65.68 ↓ -0.30 (-0.45 %)
Net Assets (Cr)	₹2,425 on 31 Oct 25
Category	Equity - Sectoral
AMC	Kotak Mahindra Asset Management Co Ltd
Rating	☆☆☆☆
Risk	High
Expense Ratio	2.01
Sharpe Ratio	-0.14
Information Ratio	-0.11
Alpha Ratio	-8.58
Min Investment	5,000
Min SIP Investment	1,000
Exit Load	0-1 Years (1%),1 Years and above(NIL)

Growth of 10,000 investment over the years.

Date	Value
31 Oct 20	₹10,000
31 Oct 21	₹18,838
31 Oct 22	₹21,380
31 Oct 23	₹26,054
31 Oct 24	₹38,938
31 Oct 25	₹38,754

Kotak Infrastructure & Economic Reform Fund SIP Returns

Total investment amount is ₹300,000
expected amount after 5 Years is ₹598,181.
Net Profit of ₹298,181 Invest Now

Returns for Kotak Infrastructure & Economic Reform Fund

Returns up to 1 year are on absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 28 Nov 25

Duration	Returns
1 Month	-1.6%
3 Month	3.2%
6 Month	1.2%
1 Year	-2%
3 Year	20.4%
5 Year	27.8%
10 Year
15 Year
Since launch	11.2%

Historical performance (Yearly) on absolute basis

Year	Returns
2024	32.4%
2023	37.3%
2022	15.6%
2021	57.3%
2020	3.4%
2019	3.6%
2018	-19.6%
2017	45.3%
2016	9.2%
2015	-0.2%

Fund Manager information for Kotak Infrastructure & Economic Reform Fund

Name	Since	Tenure
Nalin Bhatt	1 Oct 23	2.09 Yr.

Data below for Kotak Infrastructure & Economic Reform Fund as on 31 Oct 25

Equity Sector Allocation

Sector	Value
Industrials	46.88%
Basic Materials	13.9%
Consumer Cyclical	10.41%
Communication Services	10.28%
Energy	8.36%
Utility	3.95%
Financial Services	2.76%
Real Estate	2.09%
Technology	1.29%

Asset Allocation

Asset Class	Value
Cash	0.08%
Equity	99.92%

Top Securities Holdings / Portfolio

Name	Holding	Value	Quantity
Bharti Airtel Ltd (Communication Services) Equity, Since 30 Apr 20 \| BHARTIARTL	7%	₹164 Cr	800,000 ↓ -70,000
Larsen & Toubro Ltd (Industrials) Equity, Since 28 Feb 15 \| LT	5%	₹131 Cr	324,000 ↑ 50,000
Reliance Industries Ltd (Energy) Equity, Since 31 Mar 25 \| RELIANCE	5%	₹128 Cr	864,000
Shree Cement Ltd (Basic Materials) Equity, Since 31 Dec 11 \| 500387	4%	₹99 Cr	35,000
Kalpataru Projects International Ltd (Industrials) Equity, Since 31 Aug 17 \| KPIL	3%	₹80 Cr	639,927
VST Tillers Tractors Ltd (Industrials) Equity, Since 30 Apr 24 \| VSTTILLERS	3%	₹78 Cr	130,659
Solar Industries India Ltd (Basic Materials) Equity, Since 31 Oct 15 \| SOLARINDS	3%	₹75 Cr	54,000
UltraTech Cement Ltd (Basic Materials) Equity, Since 31 Mar 15 \| 532538	3%	₹72 Cr	60,000
Cummins India Ltd (Industrials) Equity, Since 30 Sep 12 \| 500480	3%	₹70 Cr	160,000
Mahindra Logistics Ltd (Industrials) Equity, Since 31 Jan 24 \| MAHLOG	3%	₹68 Cr	1,933,933 ↓ -49,332

Disclaimer:
यहां प्रदान की गई जानकारी सटीक है, यह सुनिश्चित करने के लिए सभी प्रयास किए गए हैं। हालांकि, डेटा की शुद्धता के संबंध में कोई गारंटी नहीं दी जाती है। कृपया कोई भी निवेश करने से पहले योजना सूचना दस्तावेज के साथ सत्यापित करें।